Sanofi, Earendil Labs ink up to US$ 2.56 bn AI-driven autoimmune drug deal; CDC revises childhood immunization guidelines
The New Year began with two mid-size deals centered around the use
of artificial intelligence (AI) in drug development. Sanofi...
Impressions : 1525
Madrigal’s Rezdiffra becomes first FDA-approved drug to treat NASH; Astra buys Fusion for US$ 2.4 bn
It was a week of drug approvals, as the US Food and Drug
Administration (FDA) okayed several therapies before the close of the...
Impressions : 3061
Pfizer’s oral Covid drug bags authorization in US; Biogen slashes price of its Alzheimer’s drug by half
In this week’s Phispers, we bring you updates on Biogen’s controversial Alzheimer’s drug, Novartis’ pla...
Impressions : 1890

